🏅 FDA Orphan Designation
Egaten
triclabendazole
Manufacturer: Novartis Pharmaceuticals Corporation
Indicated for:📚 Fasciolopsiasis
Indications & Usage
1 INDICATIONS AND USAGE EGATEN ® is indicated for the treatment of fascioliasis in patients 6 years of age and older. EGATEN ® tablet is an anthelmintic indicated for the treatment of fascioliasis in patients 6 years of age and older.
💙 Support Programs
View all →Egaten
Novartis Pharmaceuticals Corporation
EGATEN
Novartis
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.